These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19900256)

  • 41. Fitting Rasch model using appropriateness measure statistics.
    López Pina JA; Hidalgo Montesinos MD
    Span J Psychol; 2005 May; 8(1):100-10. PubMed ID: 15875462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5).
    Jenkinson C; Norquist JM; Fitzpatrick R
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):242-5. PubMed ID: 12531959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trials.
    Shaunfield S; Jensen S; Fisher AP; Webster K; Shahabi S; Ganguli A; Cella D
    Health Qual Life Outcomes; 2019 Dec; 17(1):185. PubMed ID: 31856850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using the Bootstrap Method to Evaluate the Critical Range of Misfit for Polytomous Rasch Fit Statistics.
    Seol H
    Psychol Rep; 2016 Jun; 118(3):937-56. PubMed ID: 27207735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity competence among infants and toddlers with developmental disabilities: Rasch analysis of the Infant Toddler Activity Card Sort (ITACS).
    Hoyt CR; L'Hotta AJ; Bauer AH; Chang CH; Varughese TE; Abel RA; King AA
    J Patient Rep Outcomes; 2021 Jan; 5(1):14. PubMed ID: 33475869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stability of INFIT and OUTFIT Compared to Simulated Estimates in Applied Setting.
    Hodge KJ; Morgan GB
    J Appl Meas; 2017; 18(4):383-392. PubMed ID: 29252207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sample Size and Probability Threshold Considerations with the Tailored Data Method.
    Wyse AE
    J Appl Meas; 2016; 17(3):293-301. PubMed ID: 28027053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Symptom management for cancer patients: a trial comparing two multimodal interventions.
    Sikorskii A; Given CW; Given B; Jeon S; Decker V; Decker D; Champion V; McCorkle R
    J Pain Symptom Manage; 2007 Sep; 34(3):253-64. PubMed ID: 17618080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Scale Anchoring with the Rasch Model.
    Wyse AE
    J Appl Meas; 2017; 18(1):43-53. PubMed ID: 28453498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies.
    Huang B; Tian L; McCaw ZR; Luo X; Talukder E; Rothenberg M; Xie W; Choueiri TK; Kim DH; Wei LJ
    Ann Intern Med; 2020 Sep; 173(5):368-374. PubMed ID: 32628533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Use of an Identifiability-Based Strategy for the Interpretation of Parameters in the 1PL-G and Rasch Models.
    Fariña P; González J; San Martín E
    Psychometrika; 2019 Jun; 84(2):511-528. PubMed ID: 30673968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating composite health measures using Rasch modelling: an illustrative example.
    Hagquist C
    Soz Praventivmed; 2001; 46(6):369-78. PubMed ID: 11851071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts.
    Stucki G; Daltroy L; Katz JN; Johannesson M; Liang MH
    J Clin Epidemiol; 1996 Jul; 49(7):711-7. PubMed ID: 8691219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infit and Outfit: Interpreting Statistical Significance and Magnitude of Misfit in Conjunction.
    DeMars CE
    J Appl Meas; 2017; 18(2):163-177. PubMed ID: 28961152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A New Extension of the Binomial Error Model for Responses to Items of Varying Difficulty in Educational Testing and Attitude Surveys.
    Wiley JA; Martin JL; Herschkorn SJ; Bond J
    PLoS One; 2015; 10(11):e0141981. PubMed ID: 26544974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using three-dimensional model-based tumour volume change to predict the symptom improvement in patients with renal cell cancer.
    Fu C; Dong J; Zhang J; Li X; Zuo S; Zhang H; Gao S; Chen L
    3 Biotech; 2024 May; 14(5):148. PubMed ID: 38711822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erratum to "General population norms for the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI)".
    Cancer; 2022 May; 128(10):2040. PubMed ID: 35285939
    [No Abstract]   [Full Text] [Related]  

  • 58. Interpretation difficulty of normal versus abnormal radiographs using a pediatric example.
    Boutis K; Cano S; Pecaric M; Welch-Horan TB; Lampl B; Ruzal-Shapiro C; Pusic M
    Can Med Educ J; 2016; 7(1):e68-77. PubMed ID: 27103955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to Investigate the Effects of Groups on Changes in Longitudinal Patient-Reported Outcomes and Response Shift Using Rasch Models.
    Hammas K; Sébille V; Brisson P; Hardouin JB; Blanchin M
    Front Psychol; 2020; 11():613482. PubMed ID: 33424726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guidelines to statistical evaluation of data from rating scales and questionnaires.
    Svensson E
    J Rehabil Med; 2001 Jan; 33(1):47-8. PubMed ID: 11480471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.